Simposi
Pharmacological Strategies Defending The Heart From Fat Attack: A New Role For Direct-Acting Oral Anticoagulants Doac? - The Epicardial Adipose Tissue (Epa), A Sick (Visceral) Fat Embracing The Heart
28 ottobre 2017 / 9.00-10.30
| 207 |
A new risk factor for coronary artery disease and atrial fibrillation Giuseppe Ambrosio (Perugia) |
| 208 |
A pharmacological target Laura Raimondi (Florence) |
| 209 |
The role of renin-angiotensin system in pathophysiology of atrial fibrillation Francesco Rossi (Naples) |
| 210 |
Fighting the pro-thrombotic risk with DOAC: the advantages of factor Xa inhibitors Fulvio Pomero (Cuneo) |